Subgroup Analyses of Pivotal and Open Label Prevention Trials Showed Effectiveness of ViroPharma's CinryzeÂ® (C1 Esterase Inhibitor [Human]) in Prevention of Angioedema Attacks in Patients with Hereditary Angioedema (HAE) Po